• Info
  • Significant Ownership

Significant Ownership of Coastlands Capital LP

Signature - Title
/s/ Mark Shamia - Chief Operating Officer of the General Partner, Coastlands Capital LLC
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Coastlands Capital LP.

Notify me when Coastlands Capital LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Coastlands Capital LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CAMP Camp4 Therapeutics Corp Common stock, par value $0.0001 per share 10% $21,452,710 4,886,722 Coastlands Capital LP 10 Sep 2025
XFOR X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 10% $7,773,911 +$37,418 2,491,638 +0.48% Coastlands Capital LP 03 Oct 2025
XLO Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share 10% $4,009,552 5,346,069 Coastlands Capital LP 04 Dec 2025
ELDN Eledon Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 6% $20,717,706 4,762,691 Matthew D. Perry 19 Nov 2025
WHWK Whitehawk Therapeutics, Inc. Common stock 6% $4,820,858 2,819,215 Coastlands Capital LP 19 Aug 2025
NEUP Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share 5.1% $1,423,200 120,000 Coastlands Capital LP 05 Nov 2025

Schedules 13D/G Reported by Coastlands Capital LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.